Implementing International Standards of Practice in A Low Resource Country by Blended Training Modules to Improve Stroke Care
Przegląd badań
Status
Warunki
Interwencja / Leczenie
Szczegółowy opis
Background: Lack of proper stroke care delivery leads to poor patient outcomes in middle- and low-income countries that can be improved by implementation of international standards. We aim to determine feasibility of implementing stroke core measures and training through blended learning modules in resource poor countries to improve stroke outcomes.
Methods: The project will be conducted across four hospitals in Pakistan in three phases. First stage will include retrospective collection of data for the preceding 4 weeks from start. In stage II, 3 months data will be collected before implementation of core measures. The stepwise training of staff will begin simultaneously, and data will continue to be collected. In stage III by the end of 3 months of stage II, core measures will be implemented as standard of care and patients will be enrolled for another 3 months. Outcomes measures will be successful implementation of the stroke care model as measured by survey done at the end and patient outcomes including in-hospital complication rates, length of hospital stay, patient and caregiver education, mRS at 3 months after discharge, post discharge complications and re-stroke rate. Data will be compared against published data from Pakistan and between patients in the first and last 3 months of the project. Statistical analyses will include appropriate mixed-effects multivariate regression models (i.e., linear and logistic) to model the relationship between clinical measures and patient safety. Degree of correlation across each symptom predictor will be measured. This study will not involve thrombolytic therapy or thrombectomy. However, the study will not provide any hindrance to implementation of such therapy and will not include such patients in analysis.
Discussion: At least one third of stroke survivors in Pakistan die due to recurrent vascular events and complications of stroke in absence of core measures. Prevention practices and stroke care are significantly underutilized in low- and middle-income countries but can be improved most efficiently by improving care delivering process without additional burden on resources by following American Heart Association "Get With The Guidelines" Stroke (GWTG-Stroke) program, Royal College of Physicians UK and European Guidelines, regardless of thrombolysis or thrombectomy. This feasibility study aims to develop a multidisciplinary comprehensive stroke team model with gradual integration of staff training, nursing care, therapy and patient education.
Typ studiów
Zapisy (Rzeczywisty)
Kontakty i lokalizacje
Lokalizacje studiów
-
-
Punjab
-
Rawalpindi, Punjab, Pakistan, 46000
- Fauji Foundation Hospital
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Metoda próbkowania
Badana populacja
Opis
Inclusion Criteria:
Acute onset of Symptoms in the last 24 hours suggestive of stroke Age > 18 years Ischemic or hemorrhagic stroke
-
Exclusion Criteria:
Presenting after 24 hours of onset of symptoms Alternate explanation for presenting symptoms (stroke mimics) Family (Surrogate Decision Maker) or next of kin/ patient refusal for participation Transfer of care from another department or hospital Care needed in another department (e.g, ICU, other department) GCS (Glasgow Coma Scale) below 5 or End of life care initiated TIA (Transient Ischemic Attack)
-
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
Kohorty i interwencje
Grupa / Kohorta |
Interwencja / Leczenie |
|---|---|
|
Retrospective 3 months cohort (admitted stroke patients)
|
|
|
Prospective pre-implementation "standard of core care quality measures" cohort
|
|
|
Prospective post-implementation "standard of core care quality measures" cohort
|
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Post Core Measure Delivery
Ramy czasowe: From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 6 months
|
• Primary outcome measure will be successful implementation of the stroke care model as measured by survey done at the end assessing engagement and ability to continue the program in future and ability to implement the program across institutions.
This will be measured by the NIHSS training, stroke education, awareness of core measures, the regularity of following the core measure and data collection.
|
From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 6 months
|
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Modified Rankin Scale
Ramy czasowe: From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 7 days
|
Modified Rankin Scale is a 6 point disability scale from 0-6, and a greater score means worse outcome.
|
From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 7 days
|
|
New ischemic stroke or Transient Ischemic Attack:
Ramy czasowe: From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 7 days
|
From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 7 days
|
|
|
Hemorrhagic transformation:
Ramy czasowe: From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 7 days
|
From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 7 days
|
|
|
Intracranial hemorrhage:
Ramy czasowe: From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 7 days
|
From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 7 days
|
|
|
Death
Ramy czasowe: From date of inclusion in the study until the date of discharge
|
From date of inclusion in the study until the date of discharge
|
Współpracownicy i badacze
Sponsor
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów (Rzeczywisty)
Zakończenie podstawowe (Rzeczywisty)
Ukończenie studiów (Oczekiwany)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Rzeczywisty)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Dodatkowe istotne warunki MeSH
Inne numery identyfikacyjne badania
- FUI/CTR/2020/8
Plan dla danych uczestnika indywidualnego (IPD)
Planujesz udostępniać dane poszczególnych uczestników (IPD)?
Informacje o lekach i urządzeniach, dokumenty badawcze
Bada produkt leczniczy regulowany przez amerykańską FDA
Bada produkt urządzenia regulowany przez amerykańską FDA
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .
Badania kliniczne na Uderzenie
-
University of ZurichNieznany